Hospices Civils de Lyon (CHU)


Klinik

Standort der Organisation:
Lyon, Frankreich


Publikationen in Kooperation mit FAU-Wissenschaftern


Go to first page Go to previous page 1 von 2 Go to next page Go to last page
Govers, T.M., Hessels, D., Vlaeminck-Guillem, V., Schmitz-Draeger, B.J., Stief, C.G., Martinez-Ballesteros, C.,... Schalken, J.A. (2019). Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study. Prostate Cancer and Prostatic Diseases, 22(1), 101-109. https://dx.doi.org/10.1038/s41391-018-0076-3
Klompmaker, S., Peters, N.A., Van Hilst, J., Bassi, C., Boggi, U., Busch, O.R.,... Roeyen, G. (2019). Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis. Annals of Surgical Oncology, 26(3). https://dx.doi.org/10.1245/s10434-018-07101-0
Capper, D., Jones, D.T.W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D.,... Pfister, S.M. (2018). DNA methylation-based classification of central nervous system tumours. Nature, 555(7697), 469-474. https://dx.doi.org/10.1038/nature26000
Pavel, M.E., Cwikla, J., Wolin, E., Phan, A., Raderer, M., Sedlackova, E.,... Caplin, M. (2018). Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension. (pp. 310-310).
Wolin, E.M., Pavel, M.E., Cwikla, J.B., Phan, A.T., Raderer, M., Sedlackova, E.,... Caplin, M.E. (2018). Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study. (pp. 358-359).
Herrick, A.L., Peytrignet, S., Lunt, M., Pan, X., Hesselstrand, R., Mouthon, L.,... Denton, C.P. (2018). Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2017-211912
Weickert, M.O., Kaltsas, G., Hoersch, D., Lapuerta, P., Pavel, M.E., Valle, J.W.,... Kulke, M.H. (2018). Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome. (pp. 357-358).
Alber, M., Kalscheuer, V.M., Marco, E., Sherr, E., Lesca, G., Till, M.,... Minassian, B.A. (2017). ARHGEF9 disease: Phenotype clarification and genotype-phenotype correlation. Neurology Genetics, 3(3). https://dx.doi.org/10.1212/NXG.0000000000000148
Peytrignet, S., Denton, C.P., Lunt, M., Hesselstrand, R., Mouthon, L., Silman, A.,... Herrick, A.L. (2017). Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology. https://dx.doi.org/10.1093/rheumatology/kex410
Cwikla, J.B., Wolin, E.M., Pavel, M.E., Phan, A.T., Raderer, M., Sedlackova, E.,... Caplin, M. (2017). Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide autogel/depot 120mg in the CLARINET open-label extension.
Blümcke, I., Spreafico, R., Haaker, G., Coras, R., Kobow, K., Bien, C.G.,... Avanzini, G. (2017). Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. New England Journal of Medicine, 377(17), 1648-1656. https://dx.doi.org/10.1056/NEJMoa1703784
Bauche, S., Vellieux, G., Sternberg, D., Fontenille, M.-J., De Bruyckere, E., Davoine, C.-S.,... Nicole, S. (2017). Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy. Journal of Neurology, 264(8), 1791-1803. https://dx.doi.org/10.1007/s00415-017-8569-x
Lewczuk, P., Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S.,... Kornhuber, J. (2017). Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization. Journal of Alzheimers Disease, 55(1), 159-170. https://dx.doi.org/10.3233/JAD-160448
Herrick, A.L., Pan, X., Peytrignet, S., Lunt, M., Hesselstrand, R., Mouthon, L.,... Denton, C.P. (2017). Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2016-210503
Atreya, R., Bloom, S., Scaldaferri, F., Gerardi, V., Admyre, C., Karlsson, A.,... Hawkey, C. (2016). Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis. Journal of Crohns & Colitis, 10(11), 1294-1302. https://dx.doi.org/10.1093/ecco-jcc/jjw103
Barnabe, C., Toepfer, D., Marotte, H., Hauge, E.-M., Scharmga, A., Kocijan, R.,... Finzel, S. (2016). Definition for Rheumatoid Arthritis Erosions Imaged with High Resolution Peripheral Quantitative Computed Tomography and Interreader Reliability for Detection and Measurement. Journal of Rheumatology, 43(10), 1935-1940. https://dx.doi.org/10.3899/jrheum.160648
Mignot, C., Von Stuelpnagel, C., Nava, C., Ville, D., Sanlaville, D., Lesca, G.,... Depienne, C. (2016). Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. Journal of Medical Genetics, 53(8), 511-22. https://dx.doi.org/10.1136/jmedgenet-2015-103451
Potorac, I., Petrossians, P., Daly, A.F., Alexopoulou, O., Borot, S., Sahnoun-Fathallah, M.,... Beckers, A. (2016). T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly. Endocrine-Related Cancer, 23(11), 871-881. https://dx.doi.org/10.1530/ERC-16-0356
Van Den Wyngaert, T., Strobel, K., Kampen, W.U., Kuwert, T., Van Der Bruggen, W., Mohan, H.K.,... Paycha, F. (2016). The EANM practice guidelines for bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 43(9), 1723-38. https://dx.doi.org/10.1007/s00259-016-3415-4
Marx, A., Stroebel, P., Badve, S.S., Chalabreysse, L., Chan, J.K.C., Chen, G.,... Travis, W.D. (2014). ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. Journal of Thoracic Oncology, 9(5), 596-611. https://dx.doi.org/10.1097/JTO.0000000000000154

Zuletzt aktualisiert 2017-16-02 um 08:41